{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T23:46:53Z","timestamp":1783640813776,"version":"3.55.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["H16C0992"],"award-info":[{"award-number":["H16C0992"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.jaip.2020.09.055","type":"journal-article","created":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T11:36:20Z","timestamp":1602329780000},"page":"1285-1294.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Longitudinal Outcomes of Severe Asthma: Real-World Evidence of Multidimensional Analyses"],"prefix":"10.1016","volume":"9","author":[{"given":"Youngsoo","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youjin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chungsoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunyoung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong-Dae","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seng Chan","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rae Woong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hae-Sim","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2020.09.055_bib1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1939-4551-7-12","article-title":"Allergic diseases and asthma: a global public health concern and a call to action","volume":"7","author":"Pawankar","year":"2014","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaip.2020.09.055_bib2","doi-asserted-by":"crossref","first-page":"763","DOI":"10.4168\/aair.2019.11.6.763","article-title":"Future risks in patients with severe asthma","volume":"11","author":"Song","year":"2019","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaip.2020.09.055_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40733-016-0029-3","article-title":"Asthma costs and social impact","volume":"3","author":"Nunes","year":"2017","journal-title":"Asthma Research and Practice"},{"key":"10.1016\/j.jaip.2020.09.055_bib4","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJM199010113231505","article-title":"Eosinophilic inflammation in asthma","volume":"323","author":"Bousquet","year":"1990","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2020.09.055_bib5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jaci.2003.10.041","article-title":"Distinguishing severe asthma phenotypes: role of age at onset and eosinophilic inflammation","volume":"113","author":"Miranda","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.09.055_bib6","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1183\/09031936.03.00261903","article-title":"The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma","volume":"22","author":"Group","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2020.09.055_bib7","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jaci.2006.11.639","article-title":"Characterization of the severe asthma phenotype by the national heart, lung, and blood institute's severe asthma research program","volume":"119","author":"Moore","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.09.055_bib8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2466-13-11","article-title":"Distribution of sputum cellular phenotype in a large asthma cohort: predicting factors for eosinophilic vs neutrophilic inflammation","volume":"13","author":"Schleich","year":"2013","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jaip.2020.09.055_bib9","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1093\/eurheartj\/ehy815","article-title":"Data-driven discovery and validation of circulating blood-based biomarkers associated with prevalent atrial fibrillation","volume":"40","author":"Chua","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jaip.2020.09.055_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-44022-8","article-title":"Machine-learning approach for the development of a novel predictive model for the diagnosis of hepatocellular carcinoma","volume":"9","author":"Sato","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaip.2020.09.055_bib11","doi-asserted-by":"crossref","first-page":"600","DOI":"10.7326\/0003-4819-153-9-201011020-00010","article-title":"Advancing the science for active surveillance: rationale and design for the Observational Medical Outcomes Partnership","volume":"153","author":"Stang","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaip.2020.09.055_bib12","first-page":"574","article-title":"Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers","volume":"216","author":"Hripcsak","year":"2015","journal-title":"Stud Health Technol Inform"},{"key":"10.1016\/j.jaip.2020.09.055_bib13","first-page":"44","article-title":"Differences between asthma and COPD in the elderly","volume":"16","author":"Sin","year":"2006","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2020.09.055_bib14","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.rmed.2009.11.024","article-title":"Association of the CCR3 gene polymorphism with aspirin exacerbated respiratory disease","volume":"104","author":"Kim","year":"2010","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2020.09.055_bib15","doi-asserted-by":"crossref","first-page":"394","DOI":"10.4168\/aair.2019.11.3.394","article-title":"Serum levels of eosinophil-derived neurotoxin: a biomarker for asthma severity in adult asthmatics","volume":"11","author":"Lee","year":"2019","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaip.2020.09.055_bib16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.pupt.2017.01.011","article-title":"Reslizumab in patients with inadequately controlled late-onset asthma and elevated blood eosinophils","volume":"43","author":"Brusselle","year":"2017","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.jaip.2020.09.055_bib17","first-page":"18","article-title":"LASSO: a feature selection technique in predictive modeling for machine learning","volume":"24","author":"Muthukrishnan","year":"2016"},{"key":"10.1016\/j.jaip.2020.09.055_bib18","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1111\/j.1365-2222.2009.03319.x","article-title":"Inflammatory biomarkers in airways of patients with severe asthma compared with nonsevere asthma","volume":"39","author":"Macedo","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2020.09.055_bib19","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.jaci.2011.12.979","article-title":"Asthma outcomes: biomarkers","volume":"129","author":"Szefler","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.09.055_bib20","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1183\/13993003.00779-2015","article-title":"Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort","volume":"46","author":"Shaw","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2020.09.055_bib21","doi-asserted-by":"crossref","first-page":"1901163","DOI":"10.1183\/13993003.01163-2019","article-title":"Characteristics and treatment regimens across ERS SHARP severe asthma registries","volume":"55","author":"van Bragt","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2020.09.055_bib22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4168\/aair.2019.11.1.43","article-title":"Characteristics of adult severe refractory asthma in Korea analyzed from the severe asthma registry","volume":"11","author":"Kim","year":"2019","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaip.2020.09.055_bib23","doi-asserted-by":"crossref","first-page":"e028150","DOI":"10.1136\/bmjopen-2018-028150","article-title":"Rate of normal lung function decline in ageing adults: a systematic review of prospective cohort studies","volume":"9","author":"Thomas","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.jaip.2020.09.055_bib24","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1183\/09031936.00130008","article-title":"Monitoring sputum eosinophils in mucosal inflammation and remodelling: a pilot study","volume":"35","author":"Chakir","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2020.09.055_bib25","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.rmed.2019.04.020","article-title":"Increase in blood eosinophils during follow-up is associated with lung function decline in adult asthma","volume":"152","author":"Graff","year":"2019","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2020.09.055_bib26","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1183\/09031936.00165106","article-title":"Severe exacerbations predict excess lung function decline in asthma","volume":"30","author":"Bai","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2020.09.055_bib27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1164\/rccm.200807-1126OC","article-title":"Severe exacerbations and decline in lung function in asthma","volume":"179","author":"O'Byrne","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2020.09.055_bib28","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1067\/mai.2000.111307","article-title":"Pathophysiology of severe asthma","volume":"106","author":"Busse","year":"2000","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.09.055_bib29","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/resp.13251","article-title":"Pathophysiology of severe asthma: we\u2019ve only just started","volume":"23","author":"King","year":"2018","journal-title":"Respirology"},{"key":"10.1016\/j.jaip.2020.09.055_bib30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.anai.2014.04.011","article-title":"High blood eosinophil count is associated with more frequent asthma attacks in asthma patients","volume":"113","author":"Tran","year":"2014","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaip.2020.09.055_bib31","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1445-5994.2011.02565.x","article-title":"Can we predict sputum eosinophilia from clinical assessment in patients referred to an adult asthma clinic?","volume":"43","author":"Yap","year":"2013","journal-title":"Intern Med J"},{"key":"10.1016\/j.jaip.2020.09.055_bib32","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jaip.2014.06.005","article-title":"High blood eosinophil count is a risk factor for future asthma exacerbations in adult persistent asthma","volume":"2","author":"Zeiger","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2020.09.055_bib33","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1513\/AnnalsATS.201310-354OC","article-title":"Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma","volume":"11","author":"Katz","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jaip.2020.09.055_bib34","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S2213-2600(16)30031-5","article-title":"Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies","volume":"4","author":"Ortega","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2020.09.055_bib35","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(12)60988-X","article-title":"Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial","volume":"380","author":"Pavord","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2020.09.055_bib36","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/thoraxjnl-2014-205634","article-title":"External validation of blood eosinophils, FENO and serum periostin as surrogates for sputum eosinophils in asthma","volume":"70","author":"Wagener","year":"2015","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2020.09.055_bib37","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.jaci.2010.12.1103","article-title":"Eosinophil and neutrophil extracellular DNA traps in human allergic asthmatic airways","volume":"127","author":"Dworski","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.09.055_bib38","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/cea.12859","article-title":"Neutrophil autophagy and extracellular DNA traps contribute to airway inflammation in severe asthma","volume":"47","author":"Pham","year":"2017","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2020.09.055_bib39","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1067\/mai.2003.1514","article-title":"Platelets are essential for leukocyte recruitment in allergic inflammation","volume":"112","author":"Pitchford","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.09.055_bib40","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jaci.2006.02.039","article-title":"The role of the mast cell in the pathophysiology of asthma","volume":"117","author":"Bradding","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.09.055_bib41","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/ACI.0000000000000273","article-title":"Predictors of asthma control in elderly patients","volume":"16","author":"Ban","year":"2016","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.09.055_bib42","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1164\/rccm.201109-1712OC","article-title":"Platelet activation, P-selectin, and eosinophil \u03b21-integrin activation in asthma","volume":"185","author":"Johansson","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2020.09.055_bib43","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jaci.2015.05.041","article-title":"Platelet activation markers overexpressed specifically in patients with aspirin-exacerbated respiratory disease","volume":"137","author":"Mitsui","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.09.055_bib44","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.jaci.2015.03.039","article-title":"Thymic stromal lymphopoietin activation of basophils in patients with allergic asthma is IL-3 dependent","volume":"136","author":"Salter","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.09.055_bib45","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.immuni.2011.03.015","article-title":"An unexpected role for uric acid as an inducer of T helper 2 cell immunity to inhaled antigens and inflammatory mediator of allergic asthma","volume":"34","author":"Kool","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.jaip.2020.09.055_bib46","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jaci.2014.08.042","article-title":"The prevalence of severe refractory asthma","volume":"135","author":"Hekking","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.09.055_bib47","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.2500\/aap.2015.36.3805","article-title":"FeNO as biomarker for asthma phenotyping and management","volume":"36","author":"Ricciardolo","year":"2015","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2020.09.055_bib48","doi-asserted-by":"crossref","first-page":"1901633","DOI":"10.1183\/13993003.01633-2019","article-title":"Clinical utility of fractional exhaled nitric oxide (FeNO) in severe asthma management","volume":"55","author":"Menzies-Gow","year":"2020","journal-title":"Eur Respir J"}],"updated-by":[{"DOI":"10.1016\/j.jaip.2021.04.004","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000}}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219820311053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219820311053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:51:58Z","timestamp":1778853118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219820311053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S2213219820311053"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2020.09.055","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longitudinal Outcomes of Severe Asthma: Real-World Evidence of Multidimensional Analyses","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2020.09.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}